Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Noopept shows therapeutic potential for Alzheimer's disease

July 11, 2006

Avicena studies ALS-08 combination therapies for ALS

July 11, 2006

Pfizer launches Zoloft in Japan

July 10, 2006

European Commission approves revision of therapeutic indication for Rebif

July 10, 2006

Recent patents describe new therapeutic agents for depression, anxiety, etc.

July 7, 2006

Neramexane potentiates the efficacy of antidepressants

July 7, 2006

Dual NOS/COX-2 inhibitors claimed in Asineks patent

July 6, 2006

A prodrug of 3-n-butylphtalide (NBP) may be useful for the treatment of cerebral ischemia

July 6, 2006

ABIO 08-01 begins Austrian phase II study in generalized anxiety disorder

July 6, 2006

Preclinical analysis of the antidepressive effects of galanin-3 receptor antagonism

July 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...